1. Goethals PE Zimmermann R . Nuclear Medicine Report and Directory. 9th ed. MEDraysintell; 2022.
2. Study of RYZ101 compared with SOC in pts w inoperable SSTR+ well-differentiated GEP-NET that has progressed following 177Lu-SSA therapy (ACTION-1). ClinicalTrials.gov website. https://clinicaltrials.gov/ct2/show/NCT05477576. Published July 28, 2022. Updated July 12, 2023. Accessed August 2, 2023.
3. Supply and clinical application of actinium-225 and bismuth-213;Morgenstern;Semin Nucl Med.,2020
4. Production and Supply of α-Particle–Emitting Radionuclides for Targeted α-Therapy
5. In vivo evaluation of free and chelated accelerator-produced actinium-225: radiation dosimetry and toxicity results;Jiang;Curr Radiopharm.,2018